Initial experience with BPaL-based regimens to treat multidrug-resistant TB.

Acuña-Villaorduña, C; Jacobson, K R; Horsburgh, C R; Canning, M; Sinha, P

Acuña-Villaorduña, C; Jacobson, K R; Horsburgh, C R; Canning, M; Sinha, P.

Afiliação

Acuña-Villaorduña C; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Jacobson KR; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Horsburgh CR; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, Departments of Epidemiology, Departments of Biostatistics, and, Departments of Global Health, Boston University School of Public Health, Boston, MA.
Canning M; Boston Public Health Commission, Boston, MA, USA.
Sinha P; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.

Int J Tuberc Lung Dis ; 27(8): 649-650, 2023 08 01.

Article em En | MEDLINE | ID: mdl-37491751

Assuntos

Antituberculosos; Tuberculose Resistente a Múltiplos Medicamentos; Humanos; Antituberculosos/uso terapêutico; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico; Protocolos Clínicos; Diarilquinolinas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Antituberculosos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google